Stent and living organ dilator

US9375329B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9375329-B2
Application numberUS-201414319399-A
CountryUS
Kind codeB2
Filing dateJun 30, 2014
Priority dateSep 27, 2007
Publication dateJun 28, 2016
Grant dateJun 28, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A stent configured to closely contact tissue in vivo by being deformed when set indwelling in vivo. The stent has a plurality of axially arranged annular members, with axially adjacent annular members being interconnected by at least one link part; and a metallic wavy-linear annular member positioned at each end of the stent. The plurality of axially arranged annular members include a plurality of linear components, the linear components including a plurality of metallic linear components and a plurality of biodegradable material-made linear components. The at least one link part is defined by one of the metallic linear components. After a predetermined period of time when the stent is left indwelling in vivo and biodegradation of the biodegradable material-made linear components proceeds, the plurality of metallic linear components and the at least one link part remain intact such that a unitary metallic structure is maintained in vivo.

First claim

Opening claim text (preview).

The invention claimed is: 1. A stent configured to closely contact tissue in vivo by being deformed when set indwelling in vivo, the stent comprising: a plurality of axially arranged annular members, with axially adjacent annular members being interconnected by at least one link part; and a metallic wavy-linear annular member positioned at each end of the stent; wherein said plurality of axially arranged annular members comprise a plurality of linear components configured to deform and exhibit a force for maintaining dilation when the stent is set indwelling in vivo, the linear components comprising a plurality of metallic linear components and a plurality of biodegradable material-made linear components; wherein the at least one link part is defined by one of the metallic linear components; and wherein, after a predetermined period of time when the stent is left indwelling in vivo and biodegradation of the biodegradable material-made linear components proceeds, the plurality of metallic linear components and the at least one link part remain intact such that a unitary metallic structure is maintained in vivo; and wherein the metallic linear components are zigzag in shape and the biodegradable material-made linear components are zigzag in shape, the metallic linear components comprising a plurality of metallic linear spiral members extending in a spiral manner in relation to an axial direction of the stent, the plurality of metallic linear spiral members being interconnected by the biodegradable material-made linear components. 2. The stent according to claim 1 , wherein the metallic linear spiral members extending in a spiral direction, the biodegradable material-made linear components each extending in a direction different from the spiral direction in which the metallic linear spiral members extend. 3. The stent according to claim 1 , wherein the metallic linear components have at least one joint part which protrudes from the at least one link part in a direction of the biodegradable material-made linear components. 4. The stent according to claim 3 , wherein the biodegradable material-made linear components envelop only a free end of the at least one joint part. 5. The stent according to claim 3 , wherein an end portion of the biodegradable material-made liner component is joined to the at least one joint part. 6. The stent according to claim 1 , wherein each annular member comprises a plurality of circumferentially arranged annular components surrounding a central axis of the stent and each elongated in an axial direction of the stent, each annular component possessing a centrally located opening and being in a collapsed form, with circumferentially adjacent annular components connected at a connection part, at least some of the connection parts connecting circumferentially adjacent annular components of a first annular member being connected by way of the link part to respective connection parts connecting circumferentially adjacent annular components of an axially adjacent second annular member, the connection parts and the link parts being composed of the metallic linear components, and at least some of the annular components each being configured such that one part of the annular component not connected to the connection part is composed of the biodegradable material-made linear component, while a remaining part is composed of the metallic linear component. 7. The stent according to claim 1 , comprising means for restraining disconnection between the metallic linear component and the biodegradable material-made linear component, the means for restraining disconnection being positioned at a joint between the metallic linear component and the biodegradable material-made linear component. 8. The stent according to claim 1 , wherein the biodegradable material-made linear components are connected to the metallic linear components at respective joints, the biodegradable material-made linear components covering an outer surface and/or an inner surface of the metallic linear component at the joint. 9. The stent according to claim 1 , wherein the linear components deformed when the stent is set indwelling in vivo comprise a multiplicity of bent or curved more easily deformable parts which are deformed when the stent is set indwelling in vivo, and joint parts which join the more easily deformable parts and are less easily deformed when the stent is set indwelling, the more easily deformable parts being comprised of the metallic linear components, and the joint parts being comprised of the biodegradable material-made linear components. 10. The stent according to claim 9 , wherein each joint part joins free ends of two respective more easily deformable parts. 11. The stent according to claim 9 , wherein the joint parts and the more easily deformable parts include means for restraining disconnection of the more easily deformable parts and the respective joint parts. 12. The stent according to claim 9 , wherein the joint part covers an outer surface and/or an inner surface of the more easily deformable part. 13. The stent according to claim 9 , wherein the joint part covers an entire surface of the more easily deformable part. 14. The stent according to claim 1 , wherein the metallic linear component is a plastically deformable metallic linear component, the stent is a tubular body possessing a diameter permitting insertion into a lumen in vivo, and the stent is expanded when a radially outwardly directed dilating force is exerted on the stent from inside the stent. 15. The stent according to claim 1 , wherein the metallic linear component is a superelastic metallic linear component, the stent possesses a hollow cylindrical shape and is compressed in a direction of a center axis of the stent when inserted into a living body, and the stent expands externally to restore a pre-compression shape when left indwelling in vivo. 16. A living organ dilator comprising a tubular shaft body part, a foldable and dilatable balloon provided at a distal portion of the shaft body part, and the stent according to claim 14 which is positioned to cover the balloon in a folded state and which is expandable by expansion of the balloon. 17. A living organ dilator comprising a sheath and the stent according to claim 15 which is accommodated in a distal portion of the sheath, and an inner tube for pushing out the stent from a distal end of the sheath, the inner tube being slidably inserted in the sheath.

Assignees

Inventors

Classifications

  • V-shaped · CPC title

  • sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable · CPC title

  • Materials at least partially resorbable by the body · CPC title

  • connected peak to peak · CPC title

  • A61F2/86Primary

    Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9375329B2 cover?
A stent configured to closely contact tissue in vivo by being deformed when set indwelling in vivo. The stent has a plurality of axially arranged annular members, with axially adjacent annular members being interconnected by at least one link part; and a metallic wavy-linear annular member positioned at each end of the stent. The plurality of axially arranged annular members include a plurality…
Who is the assignee on this patent?
Terumo Corp
What technology area does this patent fall under?
Primary CPC classification A61F2/86. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).